Charles Evan Ballantyne - Insider Trading & Ownership
Entity
Individual
Location
27 Hearthstone Road, Hopkinton, Massachusetts
Summary
The estimated net worth of Charles Evan Ballantyne is at least $711 K dollars as of April 12, 2023. Charles Evan Ballantyne is the Chief Financial Officer of Gain Therapeutics, Inc. and owns shares of Gain Therapeutics, Inc. (GANX) stock worth about $711 K.
Insider Transactions Reported by Charles Evan Ballantyne:
Sym
Company
Class
Transaction
%
Value $
Price $
Shares
Shares After
Date
Ownership
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.